Sands Capital Ventures LLC Reduces Stock Holdings in UiPath, Inc. $PATH

Key Points

• Sands Capital Ventures LLC significantly reduced its holdings in UiPath, Inc. by 75%, selling 1,188,822 shares and leaving it with 395,855 shares worth approximately $4 million.
• Multiple other investors, including Versant Capital Management and Brooklyn Investment Group, increased their stakes in UiPath during the same quarter, indicating mixed sentiment among institutional players.
• UiPath's stock has a current consensus rating of "Hold" with an average price target of $13.83, and analysts expect it to post -0.17 earnings per share for the current fiscal year.

Sands Capital Ventures LLC reduced its position in UiPath, Inc. (NYSE:PATH - Free Report) by 75.0% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 395,855 shares of the company's stock after selling 1,188,822 shares during the period. UiPath accounts for about 1.0% of Sands Capital Ventures LLC's portfolio, making the stock its 15th largest position. Sands Capital Ventures LLC owned approximately 0.07% of UiPath worth $4,077,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of PATH. Versant Capital Management Inc boosted its stake in UiPath by 198.6% in the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock worth $31,000 after purchasing an additional 1,970 shares in the last quarter. CX Institutional acquired a new stake in UiPath in the 1st quarter worth approximately $36,000. Brooklyn Investment Group boosted its stake in UiPath by 314.3% in the 1st quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock worth $46,000 after purchasing an additional 3,420 shares in the last quarter. True Wealth Design LLC boosted its stake in UiPath by 18.4% in the 4th quarter. True Wealth Design LLC now owns 5,163 shares of the company's stock worth $66,000 after purchasing an additional 801 shares in the last quarter. Finally, National Bank of Canada FI acquired a new stake in UiPath in the 1st quarter worth approximately $72,000. 62.50% of the stock is currently owned by institutional investors.

UiPath Price Performance

NYSE PATH traded up $0.2450 on Friday, hitting $11.1350. The company had a trading volume of 10,204,070 shares, compared to its average volume of 12,036,690. The company has a market capitalization of $5.96 billion, a PE ratio of -92.78, a PEG ratio of 14.63 and a beta of 1.03. The company's fifty day moving average price is $12.04 and its 200-day moving average price is $12.06. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The company had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. During the same quarter in the previous year, the firm earned $0.13 EPS. The firm's revenue was up 6.4% compared to the same quarter last year. UiPath has set its Q2 2026 guidance at EPS. FY 2026 guidance at EPS. On average, sell-side analysts anticipate that UiPath, Inc. will post -0.17 EPS for the current year.

Insider Transactions at UiPath

In other UiPath news, CEO Daniel Dines sold 9,988 shares of UiPath stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $12.00, for a total transaction of $119,856.00. Following the sale, the chief executive officer owned 4,598,388 shares of the company's stock, valued at $55,180,656. The trade was a 0.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Over the last 90 days, insiders have sold 831,310 shares of company stock worth $10,428,922. Insiders own 23.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on PATH. Royal Bank Of Canada lifted their target price on shares of UiPath from $13.00 to $15.00 and gave the stock a "sector perform" rating in a research note on Friday, May 30th. Morgan Stanley lifted their target price on shares of UiPath from $12.00 to $15.00 and gave the stock an "equal weight" rating in a research note on Monday, June 2nd. Scotiabank raised their price target on shares of UiPath from $12.00 to $13.00 and gave the stock a "sector perform" rating in a research report on Friday, May 30th. Wells Fargo & Company reissued an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. Finally, Evercore ISI raised their price target on shares of UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a research report on Friday, May 30th. Two analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $13.83.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.